Advancements in Patient Care

In 2021, Providence Holy Cross was officially designated the number one treating facility in the United States for the Y90, a procedure that targets tumors from within its feeding blood vessels, with a high dose of radiation without affecting other, healthy parts of the body. Y90 refers to the radioactive isotope Yttrium-90. 

Holy Cross is the only hospital in Providence Southern California that offers this procedure. If you would like to have a consult with Dr. Eghbalieh, please email him at: Navid.Eghbalieh@providence.org or call 818-496-4530.

Watch this brief video to learn more.

Previous Article
COVID-19 Update
COVID-19 Update

Charles Bailey, MD, infection prevention specialist provides the latest information on COVID-19, including ...

Next Article
CDI Corner
CDI Corner

Did you know overcalling Sepsis in your documentation can have downstream effects? Some helpful clinical do...